WebSep 28, 2024 · Ticker: CTXR CIK: 1506251 Form Type: 8-K Corporate News Accession Number: 0001213900-22-059746 Submitted to the SEC: Wed Sep 28 2024 4:05:14 PM EST Accepted by the SEC: Wed Sep 28 2024 Period: Wednesday, September 28, 2024 Industry: Pharmaceutical Preparations Events: Financial Exhibit; Other Events; External … WebApr 6, 2024 · View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations. Get daily stock ideas from top-performing Wall Street analysts.
Citius Pharmaceuticals, Inc. (CTXR) 8-K Earnings Release - Feb 2024
WebFeb 11, 2024 · Citius Pharmaceuticals, Inc. (CTXR) SEC Filing 10-Q Quarterly report for the period ending Thursday, December 31, 2024. Home. SEC Filings. Citius Pharmaceuticals, Inc. (CTXR) 10-Q Quarterly Report Thu Feb 11 2024; SEC Filings. CTXR Valuations. Intrinsic Value. Financial Stability. Financial Ratios. Insider Trades. WebSEC Filings for Citius Pharmaceuticals Inc (CTXR) including Annual 10-K and Quarterly 10-Q Reports. Your browser of choice has not been tested for use with Barchart.com. If … dyneley house econsult
CTXR Insider Trading - Citius Pharmaceuticals Inc - Fintel
WebSEC Filings. All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis. … WebCTXR Institutional Holdings Ownership Summary Active Positions New and Sold Out Positions 88 Institutional Holders 15,192,898 Total Shares Held Back to CTXR Overview Institutional Holdings... WebMay 14, 2024 · Citius Pharmaceuticals, Inc. (CTXR) SEC Filing 10-Q Quarterly report for the period ending Tuesday, March 31, 2024. Home. SEC Filings. Citius Pharmaceuticals, Inc. (CTXR) 10-Q Quarterly Report Thu May 14 2024; SEC Filings. CTXR Valuations. Intrinsic Value. Financial Stability. Financial Ratios. Insider Trades. dynel sheathing